Pharmacy Friends Prime Therapeutics / Magellan Rx

A Power of People edition.

In today’s episode, Many Voices, One Purpose, you'll find out the true power of people and how Prime is an organization that continues to commit to diversity, equity and inclusion efforts.

Our host Laura Spitzack, talks with Zabrina Watkins, Melissa Strong and Pat Milligan, about how we unite through common values to find our path, keep growing and fundamentally strengthen our culture and the value we bring to all our partners and the communities we are privileged to serve.

You'll discover the true meaning behind "radical welcomeness," as they explore topics related to our DEI Council, Corporate Social responsibility and what’s on the horizon. You will also hear how we unite as one culture, with one purpose, and foster partnerships to collectively craft a better, more equitable and inclusive future for our employees and the people we serve.



2023 Corporate Social Responsibility Report

Our culture

Power of People video series

https://www.primetherapeutics.com/

Jazz-laden melodies are typically the sonic output of “The Big Easy” but this week, it’s a special episode as
we take you to the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, which was in New Orleans.

Leading researchers from Prime Therapeutics and Magellan Rx are at the show, and we talk with these health care experts from our Clinical and Health Outcomes teams who are using integrated medical and pharmacy claims data to evaluate real-world drug utilization, managed care pharmacy programs, and associated costs of care for a range of conditions, including weight loss, cardiovascular disease, cancer, and multiple sclerosis. 

And, in the spirit of our host city, we have a little fun with our guests and see how much they know about “The Big Easy.” 

We even had a drop in visit from Susan Cantrell, AMCP CEO, who talked with us about how AMCP is on the forefront of pharmacy trends, but also how the organization seeks to improve access to care and reduce costs, particularly as health care trends show that the pharmacy benefit is becoming more expensive. 

Dig into the research

All newsroom content

https://www.primetherapeutics.com/

Guests:  


Landon Marshall, principal, health outcomes research 


Ben Urick, senior principal, health outcomes research 


Yuqian Liu, senior director, clinical account services 


Kyle Thompson, principal, data scientist 


Nick Friedlander, clinical program pharmacist 


Pat Gleason, assistant vice president, health outcomes 


David Eckwright, senior director, clinical project and program management 


Kristen Reimers, senior vice president of specialty clinical solutions



 

This year marks the second AMCP Annual meeting where Prime and MRx have showed up as one organization. But what does it mean for our business to show up at a crucial trade event like this? We are joined by two of our leaders responsible for putting our best foot forward at AMCP Annual, Pat Gleason, Assistant Vice President of Health Outcomes, and David Eckwright, Senior Director of Clinical Project and Program Management, to tell us more.  

We are fortunate to have Susan Cantrell, AMCP CEO, join us for a conversation on what this show means and how it continues to have an impact on the health care industry. 

Four of the Prime/MRx studies presented at AMCP relate to glucagon-like peptide-1 agonist – or GLP-1 – drugs. Earlier analysis of real-world data showed low adherence and increased cost of care for individuals in the first year of GLP-1 therapy. Prime/MRx has been a leader in GLP-1 insights, and three studies at AMCP take a fresh look at the GLP-1 data as it relates to weight loss. We have Ben Urick, Health Outcomes Reseach Senior Principal from Prime/MRx, here to walk us through the research.

Cancer care represents a rapidly rising and disproportionate share of overall health care spend. Medically integrated dispensing has been associated with better outcomes, lower waste and better patient care experiences for members receiving. Recognizing this value, payers have developed integrated dispensing networks to supplement traditional dispensing sites; however, little information is available comparing total cost of care. During this conversation with Landon Marshall, health outcomes research principal at Prime/MRx, we take a closer look at the AMCP study, Medically Integrated Dispensing of Oral Oncolytics: Real-World Cost of Care Comparison to Traditional Dispensing.